Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039872 | SCV000063563 | likely benign | not specified | 2012-01-24 | criteria provided, single submitter | clinical testing | p.Gly3937Ala in exon 50 of TTN: This variant is not expected to have clinical si gnificance because it is not located within the splice consensus sequence and ha s been identified in 0.4% (12/3164) of African American chromosomes by the NHLBI Exome Sequencing Project in a broad population (http://evs.gs.washington.edu/EV S). |
Eurofins Ntd Llc |
RCV000039872 | SCV000114328 | likely benign | not specified | 2015-08-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001703893 | SCV000238219 | likely benign | not provided | 2020-03-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000459290 | SCV000555535 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000039872 | SCV000616001 | benign | not specified | 2016-10-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001703893 | SCV002048179 | likely benign | not provided | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839488 | SCV002100721 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839489 | SCV002100722 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839490 | SCV002100723 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839487 | SCV002100724 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000039872 | SCV002571886 | benign | not specified | 2022-08-08 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.11810G>C (p.Gly3937Ala) results in a non-conservative amino acid change in the encoded protein sequence. The variant allele was found at a frequency of 0.00041 in 278438 control chromosomes, predominantly at a frequency of 0.0044 within the African or African-American subpopulation in the gnomAD database, including 1 homozygote. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 11-fold of the estimated maximal expected allele frequency for a pathogenic variant in TTN causing Dilated Cardiomyopathy phenotype (0.00039), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.11810G>C in individuals affected with Dilated Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Prevention |
RCV004534851 | SCV004727671 | likely benign | TTN-related disorder | 2021-01-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000039872 | SCV001978976 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001703893 | SCV001979914 | likely benign | not provided | no assertion criteria provided | clinical testing |